The authors studied the efficacy and cost of substituting sedation using midazolam and alfentanil for the existing regimen of diazepam and meperidine in patients requiring upper gastrointestinal endoscopy. Sixty consenting subjects were randomized to receive either meperidine 50 mg with diazepam approximately 90 #g" kg -1 (Group 19) (0,4 + 0,6 vs 1,7 • 2,4, P < 0,005) 
Upper gastrointestinal endoscopy using topical anaesthesia alone is poorly tolerated ~ and may result in reduced patient attendance at follow-up procedures. The ideal sedative for endoscopy would be highly anxiolytic and amnestle, suppress gag reflex without respiratory depression, have a rapid onset, short predictable duration of action and rapid elimination. Midazolam has a rapid onset, is redistributed twice as rapidly and eliminated ten times as quickly as diazepam after a single bolus dose. 2 Midazolam and diazepam have been studied extensively as sedative agents for upper gastrointestinal endoscopy. Midazolam with topical anaesthesia alone has been shown to provide superior patient amnesia, acceptance of endoscope insertion, and a lower incidence of thrombophlebitis than diazepam. 3,4
Narcotic-benzodiazepine combinations produce better operating conditions than benzodiazepines alone and reduce the dose of benzodiazepines required.S-7 Narcotics reduce the individual subject's variability of response to midazolam, s It is also known that meperidine increases the ventilatory depression caused by midazolam and diazepam. 9 The interaction of sedation and respiratory depression has been held responsible for an increased incidence of complications during and after endoscopy. 10-12 Alfentanil is 90% un-ionized at pH 7.4, has a greater lipid solubility than meperidine and dissociates rapidly from analgesic receptors. It also has an elimination halflife approximately half that of meperidine. ~3 These properties give alfentanil the fastest onset and the shortest duration of action of all clinically available opioids. We have compared the effect of midazolam and alfentanil on patient sedation, endoscopy conditions, heart rate, arterial saturation, recovery, of psychomotor performance and cost of medication under clinical conditions similar to those currently used to administer diazepam and meperidine.
Methods
With institutional ethics committee approval and individual informed consent, 60 patients undergoing elective upper GI endoscopy were admitted to the study. Exclusion criteria were pregnancy, chronic obstructive pulmonary disease or hepatic cirrhosis. Each subject was randomized to one of the two treatment groups (Group D or Group M) using a random number table. Following patient orientation and baseline data collection, a pulse oximeter (Nellcor N-100, Hayward, CA) probe was attached. Nasal oxygen prongs were fitted but oxygen was not administered unless SpO2 decreased below 90% for at least 30 seconds. Topical lidocaine 10% 50 mg was sprayed into each subject's oropharynx. Group M patients then received alfentanil 0.250 mg /v followed by midazolam 2.5, 3.75 or 5.0 mg /v according to weight Table I) . Patients in Group D were given meperidine 50 mg /v followed by diazepam 5.0, 7.5 or 10.0 mg iv using similar criteria. After dilution to equivalent volumes in masked syringes by the anaesthetist-observer, the drugs were administered by bolus injection via an antecubital vein by the endoscopist (DSD), who was unaware of which drugs were being used. Endoscope insertion commenced at the onset of dysarthria according to established practice. Pre-sedation arterial oxygen saturation (SpOz) and pulse rate were obtained from the pulse oximeter and recorded by the attending anaesthetist. The times of drug administration, endoscope insertion and removal and maximum pulse rate, lowest SpO2, any aversive movements or apnoeic episodes were noted for each 30 see interval. Apnoea was defined as the absence of coordinated respiratory effort over a 15 see period. Operating conditions were graded as good, satisfactory or poor by the endoscopist.
Before the procedure, each subject performed psychomotor testing using a portable four-choice reaction time (4CRT) apparatus (Kneesworth Ltd, Cambridge, UK). ~4 Patients were requested to respond to a series of stimuli, consisting of one of four light-emitting diodes illuminated in random order, by pushing the appropriate key. Reaction time and appropriateness of each response was recorded on cassette tape for later analysis. One pracflee test was performed before baseline data collection and endoscopy. At 30 and 60 min after endoscopy, subjects were asked to sit, stand and walk, were questioned about the presence of dizziness or nausea and underwent repeat 4CRT testing.
For each 4CRT test, summary statistics derived were mean reaction time and total number of errors. Test data with greater than 15% error rates were discarded. Multivariate repeated measures analysis of variance (CSS Statistica, Statsoft) were used to compare the effect of treatments and times on 4CRT variables. When appropriate, Duncan's multiple range test was used to compare the differences between individual mean values. Other continuous variables were compared using Student's t test (BMDP7V, BMD Statistical Software); the independence of categorical variables was tested using chi-square with Yates' correction (BMDP4F). 
Results
The two groups were similar with respect to age, weight, sex, and numbers taking concurrent benzodiazepine therapy (Table II) . Baseline values for pulse rate and SpO 2 did not differ significantly (Table II) . Mean dose (+SD) of diazepam used was 91 • 12 lag" kg -l and of midazolam was 47 4-6 ~tg. kg-l.
Endoscopy procedure
Endoscope insertion time was shorter and the incidence of aversive movement lower in Group M (Table III) . There were no differences in total operating time or time to orientation (Table III) . Operating conditions were rated excellent or good in the majority of patients in both groups. The proportion of patients in whom endoscopic conditions were rated poor was 5/30 in Group D and 0/30 in Group M which was not a significant difference (P = 0.053). No apnoeas or desaturations lasting >--30 sec occurred in either group. Highest pulse rate and lowest SpO 2 did not differ between the two groups. Division of subjects into groups post hoc based on age (>45 yr and _<45 yr) showed that the lowest SpO2 was higher and the decrease in SpO2 (the difference between awake baseline and the nadir) was less in the younger age group irrespective of which sedation was used (Table IV) .
Recovery from sedation
Valid 4CRT results were obtained for 58 subjects, 29 in each group. One subject was eliminated because the quality of the recording was inadequate for decoding, the other because of a control response error rate greater than 25% which probably indicates a failure to understand the test instructions. Group M subjects tended to have a longer mean control 4CRT than Group D, 657 4-200 and 575 + 129 msec respectively (P = 0.001). Thirty minutes after endoscopy, mean reaction times had increased (P = 0.0078) to 724 + 262 msec in Group M but were unchanged at 594 4-139 msec in Group D. After 60 rain Lowest SpO 2 94 + 2.9 90 + 3.7* SpO 2 decrement 3.6 + 2.2 6.1 -I-3.4* *Indicates differs significantly (P < 0.001, t test independent groups) from age _<45 yr.
recovery 4CRT decreased in Group M to 606 4-182 msec which was not different from either control value or Group D (553 4-118 msec). There were no differences in the number of errors per test. At the end of the study, 60 min after endoscopy, three Group D subjects were unable to stand and walk across the room without assistance whilst none of the Group M subjects needed help; however, this difference was not statistically significant (P = 0.24). Four Group D subjects reported nausea 30 rains after endoscopy and two in Group M. Six Group D subjects and four Group M reported dizziness when trying to stand 30 min after endoscopy. No subjects in either group were dizzy or nauseous at 60 min.
Discussion
In this otherwise healthy, predominantly middle-aged patient group, a more rapid onset of clinical sedation and fewer aversive movements were noted following midazolam/alfentanil (Group M) compared with diazepam/ meperidine (Group D). The time to ambulation or discharge was not prolonged. The results of the 4CRT test 30 min after endoscopy suggest that Group M suffered greater early residual sedation. However, the average relative impairment was only a 10% increase in reaction time compared with presedation control. Moreover, 60 rain after endoscopy, Group M subjects performed as well as Group D and control. The difficulty of designing psychomotor tests of adequate sensitivity to detect residual effects of sedatives or anaesthetics is well recognized. ~5 Choice reaction time has been shown to be adequate to detect the residual effects of midazolam 15 mg for up to 5 hr 16 and anaesthesia in surgical patients for up to eight hours. ~* Our results are consistent with several previously reported studies. Magni et al. compared meperidine/diazepam with meperidine/midazolam. Both groups received 50 mg meperidine followed by incremental doses of either diazemuls or midazolam until clinically sedated. The average initial dose of midazolam was 110 I~g" kg -I and of diazepam 170 9 kg -~ and approximately one-third of the subjects underwent ERCP for which they received hyoscine and often additional sedation. These doses which were approximately twice the amount used in our study produced greater sedation and more amnesia in the midazolam group. Psychomotor performance, measured using the Trieger test, was equally impaired by either drug for up to two hours after sedation. 17 Neither the present study nor any of the studies reviewed have shown a clear advantage in safety or more rapid recovery when midazolam is compared with diazepam. In two surveys 11,12 of endoscopic practice, patient morbidity was reported equally frequently with either drug. In the context of the single small bolus dose generally used for upper GI endoscopy clinical recovery depends almost exclusively on drug redistribution rather than elimination. Compared with diazepam, midazolam redistribution half-life is only two to four times faster 2 and this may be insufficient to confer a clinically important advantage in recovery.
In this study we anticipated that hypoxaemia might be more common in subjects receiving midazolam/alfentanil because of a more rapid onset and a more profound peak effect. Because the established procedure using diazepam/meperidine did not routinely use oxygen supplements a study goal was to determine whether a change of practice was indicated. Lower minimum saturation and larger decreases during the procedure were found in older subjects irrespective of treatment group, but in each case were only transient. Bell et al. compared midazolam (mean dose 6.0 + 2.8 mg) and diazepam (mean dose 11.5 • 6.7 rag) in subjects whose mean age was 64.3 yr and found no differences between their effect on ventilation or mean lowest SpO2 .23 Gross et al. studied SpO2 in subjects having colonoscopy with and without nasal oxygen sedated with variable doses of midazolam and meperidine. In their study minimum oxygen saturation among air breathers was related to dose of meperidine but not dose of midazolam. Others have shown that lower nadir saturations are associated with poor sedation, 24 increasing subject age, ~,26 bolus injection as opposed to slow injection 2s and operator experience. 24 In conclusion, we found no reason to support the routine use of midazolam/alfentanil in the doses studied for sedation during upper GI endoscopy. The cost of treatment for a subject between 50-99 kg in our study was C$3.20 for midazolam/alfentanil and C$0.44 for diazepam/meperidine. The study results confirm that supplementation of inspired oxygen in otherwise healthy subjects given moderate amounts of sedation is not essential. 27 The question remains whether a lower dose of midazolam/alfentanil will produce acceptable conditions for the endoscopist and the patient with faster recovery.
